# Lument Finance Trust, Inc. (LFT-PA) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_b743fe0b28f4f0067846 · retrieved 2026-08-11T16:16:03.552Z

## Overview
Lument Finance Trust, Inc. is a Maryland corporation focused on investing in, financing and managing a portfolio of commercial real estate debt investments, primarily transitional floating rate commercial mortgage loans with an emphasis on middle-market multi-family assets.

On July 24, 2026, Lument Finance Trust, Inc. received notice from the New York Stock Exchange that the Company is not in compliance with NYSE Listed Company Manual Section 802.01C because the average closing price of its common stock was less than $1.00 over a consecutive 30 trading-day period. The notice is a deficiency notice, not a delisting notice, and does not currently impact the listing or trading of the Company's common stock on the NYSE. The Company has a six-month cure period ending January 24, 2027 to regain compliance; it may do so if, on the last trading day of any calendar month during the cure period, the Company's common stock achieves a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the preceding 30 trading-day period. The Company is considering alternatives to regain compliance, including a potential reverse stock split, subject to required corporate approvals.

## Terms
- Counterparty: New York Stock Exchange · Price/share: $1

## Key dates
- Announced 2026-07-30 · Expiry 2027-01-24

## Timeline
- 2026-07-30 · 8-K (0001104659-26-088788): 8-K - Lument Finance Trust, Inc. — *Lument Finance Trust, Inc. is a Maryland corporation focused on investing in, financing and managing a portfolio of commercial real estate debt investments, primarily transitional floating rate commercial mortgage loans with an emphasis on middle-market multi-family assets.* On July 24, 2026, Lument Finance Trust, Inc. received notice from the New York Stock Exchange that the Company is not in compliance with NYSE Listed Company Manual Section 802.01C because the average closing price of its common stock was less than $1.00 over a consecutive 30 trading-day period. The notice is a deficiency notice, not a delisting notice, and does not currently impact the listing or trading of the Company's common stock on the NYSE. The Company has a six-month cure period ending January 24, 2027 to regain compliance; it may do so if, on the last trading day of any calendar month during the cure period, the Company's common stock achieves a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the preceding 30 trading-day period. The Company is considering alternatives to regain compliance, including a potential reverse stock split, subject to required corporate approvals.
  https://www.sec.gov/Archives/edgar/data/1547546/0001104659-26-088788.txt

## Citations
- 0001104659-26-088788 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926088788